Nav: Home

Nurses in Africa know when to start antiretroviral treatment

August 19, 2009

Nurses and clinical officers (non-physician clinicians, NPCs) are capable of determining when a person should receive antiretroviral therapy (ART) for HIV/AIDS. Researchers writing in BioMed Central's open access journal Human Resources for Health suggest that this should ease the strain on overstretched doctors in sub-Saharan Africa and thereby help increase access to antiretroviral therapy, particularly in rural areas.

Ashwin Vasan, from the University of Michigan and London School of Hygiene & Tropical Medicine, worked with a team of researchers in 12 Ugandan clinics to assess the degree of agreement between NPCs' decisions and those made by fully trained doctors. He said, "Nurses and clinical officers showed moderate to almost perfect agreement with physicians in their final ART recommendations. Considering that the scarcity of physicians in sub-Saharan Africa is constraining access to HIV treatment, particularly in rural clinics staffed only by NPCs, our results could lead to immediate benefits with respect to ART scale-up and decentralization."

This is the first study, either in industrialized or developing countries, to compare clinical decision-making between health care worker cadres in their prescription of ART. It offers the first evidence to support increased investment in task-shifting and training of NPCs to deliver therapy in rural primary care settings. Speaking about the potential implications of this finding, Vasan said, "Non-physician clinicians at primary care clinics should be trained, supported, and empowered to deliver antiretroviral therapy independently, with the support - but not necessarily the full-time presence - of a physician. As this a pilot, it is important to study this question further, but in the meantime programs should begin providing the necessary training, post-training support and clinical mentoring to NPCs to provide HIV/AIDS care and treatment. This will fill an important gap, particularly in rural areas, where physicians are relatively scarce, and yet where the majority of the poor reside."
-end-
Notes to Editors

1. Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
Ashwin Vasan, Nathan Kenya-Mugisha, Kwonjune J Seung, Marion Achieng, Patrick Banura, Frank Lule, Megan Beems, Jim Todd and Elizabeth Madraa
Human Resources for Health
(in press)

During embargo, article available here: http://www.human-resources-health.com/imedia/1293009671254088_article.pdf?random=780799

After the embargo, article available at journal website: http://www.human-resources-health.com/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication

2. Human Resources for Health is an open access, peer-reviewed, online journal covering all aspects of planning, producing and managing the health workforce - all those who provide health services worldwide.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

4. In conjunction with BioMed Central, Retrovirology is hosting Frontiers of Retrovirology - Complex Retroviruses, retroelements and their hosts conference in Montpellier, France, September 21 to 23, 2009. This conference will bring together leading human retrovirus researchers to review current progress and to chart future challenges.

BioMed Central

Related Antiretroviral Therapy Articles:

HIV reservoirs in humans: Immediate antiretroviral therapy makes them 100 times smaller
Thanks to an unprecedented access to blood, and biopsies of rectums and lymph nodes of people at the earliest stages of HIV infection, an international team of researchers at the University of Montreal Hospital Research Centre (CRCHUM), the US Military HIV Research Program and the Thai Red Cross AIDS Research Centre has shown that the first established reservoirs are still 'sensitive' during these early stages and could be downsized about 100 times upon immediate ART initiation.
Changes in the cost over tine of HIV antiretroviral therapy in US
Researchers calculated the average cost of recommended initial HIV antiretroviral therapy (ART) regimens in the US from 2012 to 2018 and analyzed how this cost has changed over the years.
Study suggests antiretroviral therapy does not restore disease immunity
A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy (ART), antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.
Immediate treatment with antiretroviral therapy helps infants with HIV
As part of an international collaborative effort, investigators from Brigham and Women's Hospital conducted immunological and virological testing on newborns in Botswana, finding that initiating antiretroviral therapy immediately, rather than waiting a few weeks, provided measurable benefits for infants born with HIV.
HIV may affect the brain despite ongoing antiretroviral therapy
HIV-positive patients are living longer thanks to combination antiretroviral therapy (cART), but the virus can remain in some tissues, preventing a total cure.
Being HIV positive and staying on antiretroviral therapy in Africa: A systematic review
An international team of researchers have carried out a review of the evidence examining what influences people who are HIV positive to go to health services and then stay on antiretroviral drugs in Africa.
Benefits of early antiretroviral therapy in HIV-infected children
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker -- AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Fauci: HIV remission free of antiretroviral therapy is a feasible goal
Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S.
Lyndra announces publication of feasibility study of oral once-weekly drug delivery system for HIV antiretroviral therapy in Nature Communications
Lyndra Inc., an emerging biopharmaceutical company developing oral dosage forms designed to release drug for up to a week or longer, today announced the publication of a feasibility study of an oral, once-weekly drug delivery platform for HIV antiretroviral therapy in the peer-reviewed journal Nature Communications.
HIV infection, even with antiretroviral therapy, appears to damage a growing child's brain
One of the largest and best-documented trials of children receiving early antiretroviral therapy -- the CHER clinical trial in South Africa -- finds ongoing white matter damage in HIV-positive children at the age of 7 years.
More Antiretroviral Therapy News and Antiretroviral Therapy Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.